BR9814256A - Derivados de (benzodioxano, benzofurano ou benzopirano) tendo propriedades de relaxamento fúndico - Google Patents

Derivados de (benzodioxano, benzofurano ou benzopirano) tendo propriedades de relaxamento fúndico

Info

Publication number
BR9814256A
BR9814256A BR9814256-9A BR9814256A BR9814256A BR 9814256 A BR9814256 A BR 9814256A BR 9814256 A BR9814256 A BR 9814256A BR 9814256 A BR9814256 A BR 9814256A
Authority
BR
Brazil
Prior art keywords
alkyl
hydrogen
cycloalkyl
formula
radical
Prior art date
Application number
BR9814256-9A
Other languages
English (en)
Inventor
Piet Tom Bert Paul Wigerinck
Wim Gaston Verschueren
Marc Francis Josephin Schroven
Bruyn Marcel Frans Leopold De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR9814256A publication Critical patent/BR9814256A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE (BENZODIOXANO, BENZOFURANO OU BENZOPIRANO) TENDO PROPRIEDADES DE RELAXAMENTO FúNDICO''<D>. A presente invenção dos compostos da fórmula (I), uma forma estereoquimicamente isomérica da mesma, uma forma de N-óxido da mesma ou um sal de adição de ácido farmaceuticamente aceitável da mesma, em que Alk¹ e C~ 1~-C~ 6~ alcanodiila opcionalmente substituída com hidróxi, C~ 1~-C~ 4~ alquilóxi ou C~ 1~-C~ 4~ alquilcarbonilóxi; -Z¹-Z² é um radical bivalente; R¹, R² e R³ são, cada um, independentemente selecionados de hidrogênio, C~ 1~-C~ 6~ alquila, hidróxi, halo e semelhantes; ou quando R¹ e R² estão sobre átomos de carbono adjacentes; R¹ e R² tomados juntos podem formar um radical bivalente; R^ 4^ é hidrogênio ou C~ 1~-C~ 6~ alquila; A é um radical bivalente da fórmula -NR^ 6^-Alk²-(b-1), ou N-piperidinil-(CH~ 2~)~ m~(b-2) em que m é 0 ou 1; R^ 5^ é um radical da fórmula (A), em que n é 1 ou 2; p¹ é 0 e p² é 1 ou 2; ou p¹ é 1 ou 2, e p² é 0; X é oxigênio, enxofre ou =NR^ 9^, Y é oxigênio ou enxofre; R^ 7^ é hidrogênio, C~ 1~-C~ 6~ alquila, C~ 3~-C~ 6~ cicloalquila, fenila ou fenilmetila; R^ 8^ é C~ 1~-C~ 6~alquila, C~ 3~-C~ 6~ cicloalquil fenila ou fenilmetila; R^ 9^ é ciano, C~ 1~-C~ 6~ alquila, C~ 3~-C~ 6~ cicloalquila, C~ 1~-C~ 6~ alquiloxicarbonila ou aminocarbonila; R^ 10^é hidrogênio ou C~ 1~-C~ 6~ alquila; e Q é um radical bivalente. São revelados processos para a preparação dos ditos produtos, formulações compreendendo os ditos produtos e seu uso como um remédio, em particular para as condições de tratamento que estão relacionados com o relaxamento fúndico diminuído.
BR9814256-9A 1997-12-05 1998-11-27 Derivados de (benzodioxano, benzofurano ou benzopirano) tendo propriedades de relaxamento fúndico BR9814256A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203808 1997-12-05
PCT/EP1998/007771 WO1999029687A1 (en) 1997-12-05 1998-11-27 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties

Publications (1)

Publication Number Publication Date
BR9814256A true BR9814256A (pt) 2000-10-03

Family

ID=8229014

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9814256-9A BR9814256A (pt) 1997-12-05 1998-11-27 Derivados de (benzodioxano, benzofurano ou benzopirano) tendo propriedades de relaxamento fúndico

Country Status (32)

Country Link
US (4) US6133277A (pt)
EP (1) EP1036073B8 (pt)
JP (1) JP2001525407A (pt)
KR (1) KR100591605B1 (pt)
CN (1) CN1155597C (pt)
AR (1) AR017195A1 (pt)
AT (1) ATE334125T1 (pt)
AU (1) AU748669B2 (pt)
BG (1) BG64624B1 (pt)
BR (1) BR9814256A (pt)
CA (1) CA2311669C (pt)
CO (1) CO5011114A1 (pt)
CZ (1) CZ297895B6 (pt)
DE (1) DE69835372T2 (pt)
EA (1) EA003365B1 (pt)
EE (1) EE04438B1 (pt)
ES (1) ES2270541T3 (pt)
HK (1) HK1028400A1 (pt)
HR (1) HRP20000340B1 (pt)
HU (1) HU224813B1 (pt)
ID (1) ID24616A (pt)
IL (1) IL136529A (pt)
MY (1) MY124586A (pt)
NO (1) NO320727B1 (pt)
NZ (1) NZ503603A (pt)
PL (1) PL191144B1 (pt)
SK (1) SK286268B6 (pt)
TR (1) TR200001542T2 (pt)
TW (1) TW577886B (pt)
UA (1) UA70308C2 (pt)
WO (1) WO1999029687A1 (pt)
ZA (1) ZA9811081B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
CZ20014167A3 (cs) * 1999-06-02 2002-06-12 Janssen Pharmaceutica N. V. Pyrrolidinylem, piperidinylem nebo homopiperidinylem substituované deriváty benzodioxanu, benzofuranu nebo benzopyranu
HUP0201404A3 (en) * 1999-06-02 2005-02-28 Janssen Pharmaceutica Nv Aminoalkyl substituted benzodioxan, benzofuran or benzopyran derivatives, pharmaceutical compositions containing them and their use and process for their preparations
JO2352B1 (en) 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
US6688079B2 (en) 2001-04-18 2004-02-10 Kraft Foods Holdings, Inc. Method for manufacturing flexible packages having slide closures
JPWO2003040382A1 (ja) * 2001-11-09 2005-03-03 株式会社カネカ 光学活性クロマン誘導体の製造法および中間体
ES2199086B1 (es) 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
US7071821B2 (en) * 2003-05-14 2006-07-04 Bellsouth Intellectual Property Corporation Method and system for alerting a person to a situation
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
US7470798B2 (en) 2003-09-19 2008-12-30 Edison Pharmaceuticals, Inc. 7,8-bicycloalkyl-chroman derivatives
EP1687277B1 (en) 2003-11-20 2018-04-04 Janssen Pharmaceutica NV 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
MXPA06005686A (es) 2003-11-20 2006-08-17 Janssen Pharmaceutica Nv 2-quinolinonas y 2-quinoxalinonas 7-fenilaquilo sustituidas como inhibidores de la poli(adp-ribosa)polimerasa.
ES2238015B1 (es) * 2004-01-30 2006-11-01 Cepa Schwarz Pharma, S.L. Derivados de cicloalcanodionas con actividad neuroprotectora.
US7803795B2 (en) 2004-06-30 2010-09-28 Janssen Pharmaceutica N.V. Phthalazine derivatives as parp inhibitors
UA86237C2 (uk) 2004-06-30 2009-04-10 Янссен Фармацевтика Н.В. Похідні заміщеного 2-алкілхіназолінону як інгібітори parp
CN1980913B (zh) 2004-06-30 2011-12-14 詹森药业有限公司 作为parp抑制剂的喹唑啉二酮衍生物
DE102004032277A1 (de) * 2004-07-02 2006-01-19 Basell Polyolefine Gmbh Verfahren zur racemoselektiven Synthese von ansa-Metallocenen
CA2597616A1 (en) 2005-02-17 2006-08-24 Wyeth Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
TW200716595A (en) * 2005-04-22 2007-05-01 Wyeth Corp Chromane and chromene derivatives and uses thereof
WO2008015538A2 (en) * 2006-07-31 2008-02-07 Schwarz Pharma S.L. Use of diaza- and thiaza-cycloalkanediones for preventing and/or treating pain and /or migraine
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US8503431B2 (en) * 2006-08-25 2013-08-06 Wireless Wonders Ltd. Mobile phone related indirect communication system and method
EP2134691B1 (en) 2007-03-08 2012-01-25 Janssen Pharmaceutica, N.V. Quinolinone derivatives as parp and tank inhibitors
JP5017703B2 (ja) * 2007-05-16 2012-09-05 住友ゴム工業株式会社 ビードエイペックスおよびタイヤ
US8404713B2 (en) 2007-10-26 2013-03-26 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP inhibitors
AU2009228945B2 (en) 2008-03-27 2013-05-02 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors
CN101981013B (zh) 2008-03-27 2013-05-29 詹森药业有限公司 作为parp和微管蛋白聚合抑制剂的四氢菲啶酮和四氢环戊二烯并喹啉酮
HUE046172T2 (hu) 2012-02-24 2020-02-28 Lupin Ltd Szubsztituált krománvegyületek mint kalcium-szenzor receptor modulátorok
US9040533B2 (en) 2012-12-27 2015-05-26 Purdue Pharma L.P. Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators
DE102013207163B4 (de) 2013-04-19 2022-09-22 Adidas Ag Schuhoberteil
DE102014220087B4 (de) 2014-10-02 2016-05-12 Adidas Ag Flachgestricktes Schuhoberteil für Sportschuhe
US20190290656A1 (en) 2015-12-30 2019-09-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Pt(iv) prodrugs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
US3929801A (en) * 1973-11-20 1975-12-30 Janssen Pharmaceutica Nv 2-Benzimidazolinones
GB1599296A (en) * 1977-07-06 1981-09-30 Brewster D L Ice making machine
GR71865B (pt) * 1978-03-20 1983-07-07 Ciba Geigy
DE2852945A1 (de) * 1978-12-07 1980-06-26 Boehringer Sohn Ingelheim Benzodioxanyl-hydroxyaethylpiperidyl- imidazolidinone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4239348A (en) * 1979-11-30 1980-12-16 Hughes Aircraft Company High resolution AC silicon MOS light-valve substrate
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
DE4319038A1 (de) * 1993-06-08 1994-12-15 Bayer Ag Verwendung von teilweise bekannten substituierten Chromanen als Arzneimittel, neue Wirkstoffe und Verfahren zu ihrer Herstellung
PL181385B1 (pl) * 1993-08-19 2001-07-31 Janssen Pharmaceutica Nv Nowe pochodne dihydrobenzopiranu o wlasciwosciach naczyniozwezajacych, kompozycja farmaceutyczna i sposób wytwarzania pochodnych dihydrobenzopiranu PL PL PL PL PL PL
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US5696653A (en) * 1996-12-13 1997-12-09 Phase Metrics Tooling for holding a head gimbal assembly
US6133277A (en) 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties

Also Published As

Publication number Publication date
PL341007A1 (en) 2001-03-12
NO20002074D0 (no) 2000-04-19
TW577886B (en) 2004-03-01
TR200001542T2 (tr) 2001-01-22
EA003365B1 (ru) 2003-04-24
CA2311669A1 (en) 1999-06-17
HU224813B1 (en) 2006-02-28
US20030083365A1 (en) 2003-05-01
BG104372A (en) 2000-12-29
WO1999029687A8 (en) 2000-04-13
IL136529A (en) 2003-03-12
ES2270541T3 (es) 2007-04-01
EP1036073A1 (en) 2000-09-20
IL136529A0 (en) 2001-06-14
AR017195A1 (es) 2001-08-22
NO20002074L (no) 2000-06-02
KR20010031010A (ko) 2001-04-16
ATE334125T1 (de) 2006-08-15
KR100591605B1 (ko) 2006-06-20
DE69835372T2 (de) 2007-08-09
HRP20000340A2 (en) 2001-04-30
EP1036073B1 (en) 2006-07-26
US6495547B1 (en) 2002-12-17
SK8032000A3 (en) 2001-02-12
AU748669B2 (en) 2002-06-06
ID24616A (id) 2000-07-27
SK286268B6 (sk) 2008-06-06
AU2412799A (en) 1999-06-28
ZA9811081B (en) 2000-06-22
US20030149093A1 (en) 2003-08-07
CA2311669C (en) 2010-04-27
HUP0004492A2 (hu) 2002-03-28
US6747045B2 (en) 2004-06-08
UA70308C2 (uk) 2004-10-15
NO320727B1 (no) 2006-01-23
CZ20002018A3 (cs) 2000-10-11
EP1036073B8 (en) 2006-11-15
CN1155597C (zh) 2004-06-30
EA200000616A1 (ru) 2000-12-25
WO1999029687A1 (en) 1999-06-17
HK1028400A1 (en) 2001-02-16
EE200000328A (et) 2001-08-15
DE69835372D1 (de) 2006-09-07
CZ297895B6 (cs) 2007-04-25
EE04438B1 (et) 2005-02-15
CO5011114A1 (es) 2001-02-28
PL191144B1 (pl) 2006-03-31
JP2001525407A (ja) 2001-12-11
CN1280577A (zh) 2001-01-17
HUP0004492A3 (en) 2002-04-29
NZ503603A (en) 2001-10-26
MY124586A (en) 2006-06-30
BG64624B1 (bg) 2005-09-30
US6852714B2 (en) 2005-02-08
US6133277A (en) 2000-10-17
HRP20000340B1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
BR9814256A (pt) Derivados de (benzodioxano, benzofurano ou benzopirano) tendo propriedades de relaxamento fúndico
BR0114253A (pt) Antagonistas de receptor de glutamato metabotrópico
BR0002515A (pt) Derivados de 4-arilpiperidina para o tratamento do prurido
BR9812046A (pt) Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto
NO991700L (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
FI952361A (fi) Substituoidut amidinoyhdisteet, niiden valmistus ja hoitomenetelmiä
BRPI0116607B8 (pt) derivados de glicopiranosiloxipirazol , composições farmacêuticas que os contêm e usos dos mesmos
AU2134402A (en) Antiviral agents
BR0010366A (pt) Composto, composição farmacêutica, método de preparar um composto, e, composto para uso em terapia
AR050045A1 (es) Derivados de pirrolo[3,4-c]pirazol activos como inhibidores de quinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden
AR015312A1 (es) Compuestos inhibidores no peptidilicos de la union a las celulas dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunesy respiratorias, composicion farmaceutica y uso de los compuestos en la preparacion de medicamentos
ES2147913T3 (es) Uso de propilenoxidopolioles iniciados con toluilendiamina en espumas rigidas de poliuretano.
BR0100155A (pt) Azabenzimidazóis aril substituìdos e sua utilização no tratamento de hiv e doenças relacionadas com aids
GR3017028T3 (en) Amidino compounds, their manufacture and use as medicament.
BR0009847A (pt) Kit de partes, método de preparação de um kit de partes, formulação farmacêutica, método de tratamento de uma condição na qual inibição de trombina é requerida ou desejada, e, uso de um inibidor de trombina, ou de um derivado farmaceuticamente aceitável do mesmo
BRPI0408744A (pt) 4-feniltetrahidroisoquinolinas substituìdas, processos para preparação das mesmas, seu uso como medicamento, bem como medicamento que contém as mesmas
BR0008321A (pt) Secretagogos de hormÈnio de crescimento
BR9814055A (pt) Composto, composição farmacêutica, processo para o tratamento de uma doença alérgica, uso do composto, e, processos para preparar e para produzir um composto
BRPI0417007A (pt) agentes antivirais de diazaindol-dicarbonil-piperazinila
BR0011247A (pt) Derivados (benzodioxano, benzofurano ou benzopirano) de pirrolidinila, piperidinila ou homopiperidinila substituìdos
BR0011237A (pt) Derivados de benzodioxano, benzofurano ou benzopirano substituìdos com aminoalquila
AR043253A1 (es) 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas
UY26877A1 (es) Compuestos pirazol-tiazol, composiciones farmacéuticas que los contienen, y su modo de empleo para inhibir quinasas ciclino- dependientes
NO180300C (no) Hydroksyamidinderivater, farmasöytiske sammensetninger inneholdende dem og deres anvendelse for fremstilling av farmasöytiske sammensetninger
BR0010381A (pt) Método de tratamento da trombose em um mamìfero, e uso de uma combinação de (i) um inibidor do fator xa, e (ii) um composto selecionado do grupo que consiste em aspirina, tpa, um antagonista gpiib/iiia, heparina de baixo peso molecular e heparina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE O MESMO NAO ATENDE AO DISPOSTO NOS ARTIGOS 8O, 13 , 24E 25 DA LEI NO 9279/96

B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/4166, C07D 405/14, C07D 405/12, A61K 31/495, A61P 1/14

Ipc: A61K 31/4166 (2009.01), C07D 405/14 (2009.01), C07

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.